Katherine MacLean

Katherine MacLean

Dr. Katherine MacLean is a research scientist with expertise in studying the effects of mindfulness meditation and psychedelics. At Johns Hopkins University School of Medicine, she conducted legal clinical trials of psilocybin, the primary chemical found in “magic mushrooms”. In 2015, she co-founded and was the first director of the Psychedelic Education and Continuing Care Program in New York (http://www.psychedelicprogram.com), where she led training workshops and monthly integration groups focused on increasing awareness and reducing risks of psychedelic use. She is currently a sub-investigator (part of a therapy team) in a federally-approved clinical trial of MDMA-assisted therapy for post-traumatic stress disorder.

Psychedelic Ethics: The Good, the Bad, and the Ugly

I have been deeply disappointed and angry at both men and women in our community who would rather sweep these experiences under the rug and avoid all criticisms that could make it harder for the mainstream to “accept” us and our drugs of choice.